Seems like we are done with MIS for cervical cancer. Even distance from margin was the same and the “less worrisome” uterine manipulators were showed higher rates of recurrence. The only thing left is the CO2....
Dr. Katherine Kurnit, of @MDAndersonNews, walked us through her study comparing whether a gynecologic or gastrointestinal regimen is better for patients with mucinous ovarian cancer who are dispositioned to receive chemo. Stay tuned for the interview! #SGOWinter#SGO2019@SGO_org
Amazing data for the olaparib maintenance after the first line chemotherapy in advanced #ovariancancer with somatic it germline BRCA mutation presented at #ESMO18#PrecisionMedicine